Table: begin end state 1 251 cytoplasmic 252 278 transmembrane 279 289 non-cytoplasmic 290 313 transmembrane 314 324 cytoplasmic 325 351 transmembrane 352 370 non-cytoplasmic 371 391 transmembrane 392 409 cytoplasmic 410 429 transmembrane 430 451 non-cytoplasmic 452 475 transmembrane 476 486 cytoplasmic 487 507 transmembrane 508 512 non-cytoplasmic 513 533 transmembrane 534 543 cytoplasmic 544 574 transmembrane 575 587 non-cytoplasmic
Input: >GFF3783 MNLIIVTACPQGVATRFLAARALERAANRRGWSVTTDTRGPDGKTDNKPSEAAIQQADLV IAAVGIPVNLDVYAGKRLLQIPVTAALPDPDAILTRAQAEATPWDPAMASQESIATSTAV GSTSAGKRIVAVTACPTGVAHTFMAAEALTAAAQSAGHKIRVETQGSVGAQDPLTEEEIA AADVVILACDIEVDPGRFSGKRVWRTSTGAALKKPADTIRDALEQAVVLNAGQKKTSGAS GSGEKKGPYKHLLTGVSFMLPMVVAGGLLIALSFVFGIEAFQEEGTLAAALMQIGGGTAF KLMIPLLAGYIAWSIADRPGLAPGMIGGFLAGELGAGFLGGIVAGFLAGYVARFISQKLP MPESIESLKPILIIPLLASLVTGLGMIYVIGEPMAAIMGALTGFLEGMGTTNAILLGGIL GAMMCFDLGGPVNKAAYTFGVGLLSEGSGGSAPMAAIMAAGMVPAIGMGVASFIARRKFA EAERQAGRASFVLGLCFISEGAIPFMAKDPLRVIPVCMIGGAITGALSMLFTVKLMAPHG GLFVLAIPNAVSAVLPYLIAIAVGSLVIGFGYALLKTGKAEVTAAVS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server